Visual-Evoked-Response-Supported Outcome of Intravitreal Erythropoietin in Management of Indirect Traumatic Optic Neuropathy

Table 4

Comparisons of means of BCVA, VER latency, and amplitude in patients receiving two EPO injections.

	(BCVA LogMAR) 5 patients	VER latency (m·sec) 4 patients	VER amplitude (microns), 4 patients
Preinjection (baseline)	2.1 ± 0.7	156.5 ± 13.48	9 ± 9.3
After first injection	1.5 ± 0.84	142.25 ± 18	17.3 ± 10.3
After second injection	1.13 ± 0.8	115.8 ± 19.24	16.38 ± 11
Repeated measure ANOVA test
Percent of patients improved after second injection	60%	100%	50%
Before and after first injection
Before and after second injection
After first and second injection

Paired t-test value. BCVA LogMAR: best-corrected visual acuity in logarithm minimal angle of resolution; VER: visual evoked response.